Bibliography
- UNICEF. State of the World‘s Children. (2008)
- Jeena PM : Can the burden of pneumonia among HIV-infected children be reduced?Bull. World Health Organ.86(5), 5 (2008).
- Obaro SK , MadhiSA: Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?Lancet Infect. Dis.6(3), 150–161(2006).
- Rudan I , Boschi-PintoC, BiloglavZ, MulhollandK, CampbellH: Epidemiology and etiology of childhood pneumonia.Bull. World Health Organ.86(5), 408–416(2008).
- Zwi KJ , PettiforJM, SoderlundN: Paediatric hospital admissions at a South African urban regional hospital: the impact of HIV, 1992–1997.Ann. Trop. Paediatr.19(2), 135–142(1999).
- UNICEF and World Health Organization. Pneumonia: the forgotten killer of children. (2006)
- World Health Organization. The World Health Report. (2004)
- Special theme: prevention and control of childhood pneumonia. Bull. World Health Organ.86(5), 321–416(2008).
- Dherani M , PopeM, MascarenhasM, SmithKR, WeberM, BruceN: Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis.Bull. World Health Organ.86(5), 390–398(2008).
- World Health Organization: Indoor air pollution and lower respiratory tract infections in children. Presented at: International Society of Environmental Epidemiology. Paris, France, 4 September 2006. (2007)
- Roth DE , CaulfieldLE, EzzatiM, Black RE: Acute lower respiratory infections in childhood: opportunities for reducing the global burden through nutritional interventions. Bull. World Health Organ.86(5), 356–364(2008).
- Bose A , ColesCL, GunavathiHJet al.: Efficacy of zinc in the treatment of severe pneumonia in hospitalized children <2 years old. Am. J. Clin. Nutr.83(5), 1089–1096(2006).
- Brooks WA , YunusM, SantoshamMet al.: Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet363(9422), 1683–1688(2004).
- Chintu C , BhatG, WalkerASet al.: Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet364, 1865–1871(2004).
- Gona P , Van Dyke RB, Williams PL et al.: Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA296(3), 292–300(2006).
- Luby S : The role of handwashing in improving hygiene and health in low-income countries.Am. J. Infect. Control29(4), 239–240(2001).
- Madhi SA , LevineO, HajjehR, Mansoor OD, Cherian T: Vaccines to prevent pneumonia and improve child survival. Bull. World Health Organ.86, 365–372(2008).
- Chandran A , WattJP, SantoshamM: Prevention of Haemophilus influenzae type b disease: past success and future challenges.Expert Rev. Vaccines4(6), 819–827(2005).
- Adegbola RA , SeckaO, LahaiGet al.: Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet366(9480), 144–150(2005).
- Mulholland K , HiltonS, AdegbolaRet al.: Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet349(9060), 1191–1197(1997).
- Gessner BD , AdegbolaR: The impact of vaccines on pneumonia: Key lessons from Haemophilus influenzae type b conjugate vaccines.Vaccine26(Suppl. 2), B3–B8 (2008).
- Klugman KP , MadhiSA, HuebnerRE, KohbergerR, MbelleN, PierceN: A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.N. Engl. J. Med.349(14), 1341–1348(2003).
- Cutts FT , ZamanSM, EnwereGet al.: Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet365(9465), 1139–1146(2005).
- World Health Organization: Technical bases for the WHO recommendations on management of pneumonia in children at first level health facilities. (WHO/ARI/91.20) (1991).
- World Health Organization: Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources. (2005).
- Scott JA , BrooksWA, PeirisJS, Holtzman D, Mulholland EK: Pneumonia research to reduce childhood mortality in the developing world. J. Clin. Invest.118(4), 1291–1300(2008).
- Lim YW , SteinhoffM, GirosiFet al.: Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature444(Suppl. 1), 9–18(2006).
- Sazawal S , BlackRE: Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials.Lancet Infect. Dis.3(9), 547–556(2003).
- Graham SM , EnglishM, HazirT, Enarson P, Duke T: Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings. Bull. World Health Organ.86(5), 349–355(2008).
- World Health Organization: The management of acute respiratory infections in children. Practical guidelines for outpatient care. (1995).
- World Health Organization: Handbook IMCI Integrated Management of Childhood Illness. (WHO/FCH/CAH/00.12) (2000).
- Marsh DR , GilroyKE, Van de WR, Wansi E, Qazi S: Community case management of pneumonia: at a tipping point? Bull. World Health Organ.86(5), 381–389(2008).
- World Health Organization and The United Nations Children’s Fund: WHO/UNICEF joint statement. Management of pneumonia in community settings. (2004).
- Straus WL , QaziSA, KundiZ, NomaniNK, SchwartzB: Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group.Lancet352(9124), 270–274(1998).
- Cardoso MR , Nascimento-CarvalhoCM, FerreroFet al.: Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. Arch .Dis. Child.93(3), 221–225(2008).
- Kallander K , HildenwallH, WaiswaP, GaliwangoE, PetersonS, PariyoG: Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case-series study.Bull. World Health Organ.86(5), 332–338(2008).
- Mulholland EK , SmithL, CarneiroI, BechercH, LehmannD: Equity and child-survival strategies.Bull. World Health Organ.86(5), 399–407(2008).
- Courtoy I , LandeAE, TurnerRB: Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia.Clin. Pediatr. (Phila)28(6), 261–264(1989).
- Ghafoor A , NomaniNK, IshaqZet al.: Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan. Rev. Infect. Dis.12(Suppl. 8), S907–S914 (1990).
- Forgie IM , O‘NeillKP, Lloyd-EvansNet al.: Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. Pediatr. Infect. Dis. J.10(1), 33–41(1991).
- Tupasi TE , LuceroMG, MagdangalDMet al.: Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila. Rev. Infect. Dis.12(Suppl. 8), S929–S939 (1990).
- Madhi SA , KlugmanKP: A role for Streptococcus pneumoniae in virus-associated pneumonia.Nat. Med.10(8), 811–813(2004).
- O‘Brien KL , WaltersMI, SellmanJet al.: Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis.30(5), 784–789(2000).
- Hazir T , QaziSA, NisarYBet al.: Can WHO therapy failure criteria for non-severe pneumonia be improved in children aged 2–59 months? Int. J. Tuberc. Lung Dis.10(8), 924–931(2006).
- Hazir T , LatifE, QaziSAet al.: Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet360(9336), 835–841(2002).
- Agarwal G , AwasthiS, KabraSK, KaulA, SinghiS, WalterSD: Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.Br. Med. J.328(7443), 791 (2004).
- Addo-Yobo E , ChisakaN, HassanMet al.: Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet364(9440), 1141–1148(2004).
- Hazir T , FoxLM, NisarYBet al.: Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet371(9606), 49–56(2008).
- Jeena P , TheaDM, MacLeodWBet al.: Failure of standard antimicrobial therapy in children aged 3–59 months with mild or asymptomatic HIV infection and severe pneumonia. Bull.World Health Organ.84(4), 269–275(2006).
- McNally LM , JeenaPM, GajeeKet al.: Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet369(9571), 1440–1451(2007).
- Onyango FE , SteinhoffMC, WafulaEM, WariuaS, MusiaJ, KitonyiJ: Hypoxaemia in young Kenyan children with acute lower respiratory infection.Br .Med. J.306(6878), 612–615(1993).
- Duke T , WandiF, JonathanMet al.: Improved oxygen systems for childhood pneumonia: a multihospital effectiveness study in Papua New Guinea.Lancet (2008) (Epub ahead of print).
- Smyth A , CartyH, HartCA: Clinical predictors of hypoxaemia in children with pneumonia.Ann. Trop. Paediatr.18(1), 31–40(1998).
- World Health Organization Program for the Control of Acute Respiratory Infections: Oxygen therapy for acute respiratory infections in young children in developing countries. (1993).
- Nolan T , AngosP, CunhaAJet al.: Quality of hospital care for seriously ill children in developing countries. Lancet357(9250), 106–110(2001).
- World Health Organization: Improving paediatric referral care in the context of child survival activities and IMCI, Review of processes to improve paediatric care in small hospitals in developing countries. (2008).
- Campbell H , DukeT, WeberM, EnglishM, CaraiS, TamburliniG: Global initiatives for improving hospital care for children: state of the art and future prospects.Pediatrics121(4), E984–E992 (2008).
- Selwyn BJ : The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers.Rev. Infect. Dis.12(Suppl. 8), S870–S88 (1990).
- Scott JA : The global epidemiology of childhood pneumonia 20 years on.Bull. World Health Organ.86(6), 494–495(2008).
- John TJ , CherianT, SteinhoffMC, Simoes EA, John M: Etiology of acute respiratory infections in children in tropical southern India. Rev. Infect. Dis.13(Suppl. 6), S463–S469 (1991).
- Scott A , BrooksA, PeirisJS, HolzmanD, MulhollanEK: Pneumonia research to reduce childhood mortality in the developing world.J. Clin. Invest.118(4), 1291–1300(2008).
- Cripps AW , LeachAJ, LehmannD: Pneumococcal vaccination in developing countries.Lancet368(9536), 644 (2006).
- Cripps AW , LeachAJ, LehmannD, Benger N: Fifth International Symposium on Pneumococci and Pneumococcal Diseases, Alice Springs, Central Australia, 2–6 April 2006. Vaccine25(13), 2361–2365(2007).
- Rudan I , TomaskovicL, Boschi-PintoC, CampbellH: Global estimate of the incidence of clinical pneumonia among children under five years of age.Bull.World Health Organ.82(12), 895–903(2004).
- Qazi S , WeberM, Boschi-PintoC, Cherian T: Global Action Plan for the Prevention and Control of Pneumonia (GAPP). Report of an informal consultation. Gex, France. 5–7 March 2007. Geneva, WHO (2008).
Websites
- United Nations. United Nations Millennium Development Goals. www.un.org/millenniumgoals (Accessed 10June2008).
- Global Alliance for Vaccines and Immunization. www.gavialliance.org
- Child Health Epidemiology Reference Group (CHERG). www.who.int/child_adolescent_health/data/cherg/en/index.html